Olawuyi Racett Nigeria Ltd.
London, EC1V 2NX, United Kingdom
NCT Number: NCT06256172
MEDLINK IS A POCKET-SIZED MEDLINK is a pocket-sized, verbally interactive, programmable medical device that allows physicians to select which medical measurements they would like to take for a specific patient. The Physiological Parameters that can be measured by MEDLINK include, but is not limited to: Electrocardiography (ECG), Blood Pressure, Heart Rate, Blood Glucose, Pulse Rate, Blood Oxygen Saturation (SPO2), Electromyography (EMG) body temperature, and Respiratory Data. MEDLINK is a pocket-sized, verbally interactive, programmable medical device that allows physicians to select which medical measurements they would like to take for a specific patient.
When the patient takes MEDLINK home and switches it on, the device verbally guides the patient to acquire the measurements requested by the his or her physician.
This information is transmitted to the physican's email for medical analysis, check up and/or follow up.
This Study was executed by TWO (2) MEDICAL CONSULTANTS: Dr. Michael Olawuyi ([email protected]) and Dr, Matthew Olawuyi ([email protected])
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
London, EC1V 2NX, United Kingdom
MEDLINK is a pocket-sized, verbally interactive, programmable medical device that allows physicians to select which medical measurements they would like to take for a specific patient. The Physiological Parameters that can be measured by MEDLINK include, but is not limited to: Electrocardiography (ECG), Blood Pressure, Heart Rate, Blood Glucose, Pulse Rate, Blood Oxygen Saturation (SPO2), Electromyography (EMG) body temperature, and Respiratory Data. After programming of the device by the Physician, MEDLINK can be given to the desired patient to take home for Remote Patient Monitoring (RPM).
When the patient switches on the device at home, MEDLINK verbally guides the patient to acquire the measurements requested by his or her Physician. This information is automatically and wirelessly transmitted to the Physician's Mobile Phone and Email Address for medical analysis, check up, and/or follow up. MEDLINK has its own software application that allows the Physician to view and analyse the measured Physiological Parameters for any Patient. MEDLINK also has the potential to allow Patient-Physician Communication during the RPM Period.
One of the key innovations of MEDLINK is that it is able to acquire a diverse range of physiological parameters. This makes it useful to physicians in different areas of specialization in the medical field. In addition to this, MEDLINK also accurately measures all Physiological Parameters of the Patient through a single digit finger being inserted into the appropriate position in the pocket-device, making it extremely easy to use. MEDLINK is the first medical device that performs blood glucose measurement using Infrared Technology, as opposed to the standardized lancet finger-pricking technology.
MEDLINK allows Physicians in any specialization to monitor patients outside of the hospital setting for as long as is needed. It can be used to monitor patients after they have been discharged from the hospital. It also allows individuals to have quality access to basic health care.
Ten Patients were recruited for this Study and tested the use of MEDLINK in measuring physiological parameters and providing remote access to basic health care.
This Study was executed by TWO (2) MEDICAL CONSULTANTS: Dr. Michael Olawuyi ([email protected]) and Dr, Matthew Olawuyi ([email protected])
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The 10 Patients enrolled in this arm tested the ue of Medlink in Measuring and reporting their Physiological Paramters in Oder to remotely obtain access to health care for the following diseases: Myasthenia Gravis, Hypertension, Chronic Heart Failure, Diabetes Mellitus, and Chronic Obstruction Pulmonary Disorder.
Time frame: Measurement is done Once daily for 2 weeks
1 PQRS Interval is acquired.
Time frame: Measurement is done Once daily for 2 weeks
Acquisition of 5 readings of Blood Pressure (Systolic and Diastolic Pressure) in mmHg and the average value is reported
Time frame: Measurement is done Once daily for 2 weeks
Acquisition of 5 readings of Heart Rate in bpm and the average vallue is reported
Time frame: Measurement is done Once daily for 2 weeks
Acquisition of 5 readings of Blood Glucose in mmol/L and the average value is reported
Time frame: Measurement is done Once daily for 2 weeks
Acquisition of 5 readings of Pulse in bpm and the average value is reported
Time frame: Measurement is done Once daily for 2 weeks
Acquisition of 5 readings of SPO2 or Blood Oxygen Saturation and the average value is reported
Time frame: Measurement is done Once daily for 2 weeks
Acquisition of 5 readings of Electromyography or Muscle Strength Power in the Beta band and the average value is reported
Time frame: Measurement is done Once daily for 2 weeks
Acquisition of 5 readings of Body Temperature in Degrees Celcius and the average value is reported
Time frame: Measurement is done Once daily for 2 weeks
Acquisition of 5 readings of Respiratory Data (FEV1, FVC, FEV1/FVC ratio) in L and the average value is reported
Olawuyi Racett Nigeria Ltd
Industry
Acronym: Medlink
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05543720
Behavior, Behavioral Symptoms
Brampton, Ontario, Canada
View Trial DetailsNCT05723185
Body Temperature Changes, Cardiovascular Diseases
Milan, Italy
View Trial DetailsNCT03987633
Arrhythmias, Cardiac, Arterial Occlusive Diseases
Wolverhampton, West Midlands, United Kingdom
View Trial DetailsNCT05574699
Cardiovascular Diseases, Chronic Disease
Baltimore, Maryland, United States
View Trial Details